article thumbnail

Do patients care about accelerated approval drugs?

World of DTC Marketing

The program was codified into law under the Food and Drug Safety and Innovation Act (FDASIA) in 2012. Of course, they should, but in the end, it’s going to come down to trust in their doctor and the FDA. Should patients be made aware that the drug they are being prescribed is an “accelerated approval drug”?

Patients 200
article thumbnail

The need for mental healthcare is great

World of DTC Marketing

The national rate of suicidal ideation among adults has increased every year since 2011-2012. Every new doctor and therapist a patient visits must be given a copy of those laws that the patient must read and sign. Suicidal ideation continues to increase among adults in the U.S. who are going untreated. These laws are called HIPPA.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

UK agency pilots biobank to study links between genetics and drug side effects

Pharmaceutical Technology

This would ideally allow doctors to use rapid genomic screening tests that can help them to select the safest potential treatment for a patient. The 100,000 Genomes Project was initially announced in December 2012, with Genomics England being launched later in July 2013.

article thumbnail

The responsibility for chronic health issues

World of DTC Marketing

The COVID pandemic hopefully will be winding down soon and as people are returning to the doctors offices they are being diagnosed with a chronic health conditions, many of which can be prevented. percent annually in youngsters 10-19 between 2002 and 2012. According to a study, few Americans have a lifestyle that is considered healthy.

Insurance 185
article thumbnail

Whistleblower gets $250m as Biogen settles US kickbacks case

pharmaphorum

Biogen has finalised a $900 million payment to settle a whistleblower lawsuit claiming that it paid kickbacks to US doctors to prescribe its multiple sclerosis drugs. The suit was filed in 2012 by Bawduniak, acting on behalf of the US government.

article thumbnail

Battling breast cancer with precision medicine

pharmaphorum

It was the summer of 2012 and I had just turned 37, my son was about to celebrate his first birthday and my daughter had just started school. Although I had stopped breastfeeding three months earlier, my doctor was convinced I was suffering from a bad case of mastitis – an inflammation usually caused by breastfeeding. A second opinion.

article thumbnail

PM360 2022 Trailblazer Awards Product Launch of the Year Winner GEMTESA

PM360

received FDA approval for once-daily GEMTESA—the first new oral OAB medication approved by the FDA since 2012. The treatment gap is evident: of those 30 million Americans with OAB, only 16 million have seen a doctor about the condition and only three million people are on treatment at any given time.